178 related articles for article (PubMed ID: 36535404)
1. Kinins and their B
Brusco I; Fialho MFP; Becker G; Brum ES; Favarin A; Marquezin LP; Serafini PT; Oliveira SM
Life Sci; 2023 Feb; 314():121302. PubMed ID: 36535404
[TBL] [Abstract][Full Text] [Related]
2. Kinins and their B
Brusco I; Justino AB; Silva CR; Fischer S; Cunha TM; Scussel R; Machado-de-Ávila RA; Ferreira J; Oliveira SM
Biochem Pharmacol; 2019 Oct; 168():119-132. PubMed ID: 31254493
[TBL] [Abstract][Full Text] [Related]
3. Kinin B
Brusco I; Becker G; Palma TV; Pillat MM; Scussel R; Steiner BT; Sampaio TB; Ardisson-Araújo DMP; de Andrade CM; Oliveira MS; Machado-De-Avila RA; Oliveira SM
Sci Rep; 2023 Mar; 13(1):4418. PubMed ID: 36932156
[TBL] [Abstract][Full Text] [Related]
4. Ca2+ signalling of kinins in cells expressing rat, mouse and human B1/B2-receptor.
Zubakova R; Gille A; Faussner A; Hilgenfeldt U
Int Immunopharmacol; 2008 Feb; 8(2):276-81. PubMed ID: 18182240
[TBL] [Abstract][Full Text] [Related]
5. Kinin B1 receptors contributes to acute pain following minor surgery in humans.
Hamza M; Wang XM; Adam A; Brahim JS; Rowan JS; Carmona GN; Dionne RA
Mol Pain; 2010 Feb; 6():12. PubMed ID: 20152050
[TBL] [Abstract][Full Text] [Related]
6. The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: evidence for the involvement of astrocytes.
Dutra RC; Bento AF; Leite DF; Manjavachi MN; Marcon R; Bicca MA; Pesquero JB; Calixto JB
Neurobiol Dis; 2013 Jun; 54():82-93. PubMed ID: 23454198
[TBL] [Abstract][Full Text] [Related]
7. The kallikrein-kinin system: current and future pharmacological targets.
Moreau ME; Garbacki N; Molinaro G; Brown NJ; Marceau F; Adam A
J Pharmacol Sci; 2005 Sep; 99(1):6-38. PubMed ID: 16177542
[TBL] [Abstract][Full Text] [Related]
8. [Bradykinin antagonist: current status and perspective].
Hirayama Y; Kayakiri H
Nihon Yakurigaku Zasshi; 2002 Jan; 119(1):45-53. PubMed ID: 11862756
[TBL] [Abstract][Full Text] [Related]
9. The kinin B1 receptor regulates muscle-specific E3 ligases expression and is involved in skeletal muscle mass control.
Parreiras-E-Silva LT; Reis RI; Santos GA; Pires-Oliveira M; Pesquero JB; Gomes MD; Godinho RO; Costa-Neto CM
Clin Sci (Lond); 2014 Aug; 127(3):185-94. PubMed ID: 24498923
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of angiotensin I converting enzyme potentiate fibromyalgia-like pain symptoms via kinin receptors in mice.
Brusco I; Justino AB; Silva CR; Scussel R; Machado-de-Ávila RA; Oliveira SM
Eur J Pharmacol; 2021 Mar; 895():173870. PubMed ID: 33476653
[TBL] [Abstract][Full Text] [Related]
11. Nonpeptide antagonists for kinin receptors.
Altamura M; Meini S; Quartara L; Maggi CA
Regul Pept; 1999 Mar; 80(1-2):13-26. PubMed ID: 10235630
[TBL] [Abstract][Full Text] [Related]
12. Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.
Charignon D; Späth P; Martin L; Drouet C
Expert Opin Pharmacother; 2012 Oct; 13(15):2233-47. PubMed ID: 22970904
[TBL] [Abstract][Full Text] [Related]
13. Kinin B1 and B2 receptor expression in osteoblasts and fibroblasts is enhanced by interleukin-1 and tumour necrosis factor-alpha. Effects dependent on activation of NF-kappaB and MAP kinases.
Brechter AB; Persson E; Lundgren I; Lerner UH
Bone; 2008 Jul; 43(1):72-83. PubMed ID: 18467203
[TBL] [Abstract][Full Text] [Related]
14. Kinin-B2 receptor mediated neuroprotection after NMDA excitotoxicity is reversed in the presence of kinin-B1 receptor agonists.
Martins AH; Alves JM; Perez D; Carrasco M; Torres-Rivera W; Eterović VA; Ferchmin PA; Ulrich H
PLoS One; 2012; 7(2):e30755. PubMed ID: 22348022
[TBL] [Abstract][Full Text] [Related]
15. B
Soley BDS; Silva LM; Mendes DAGB; Báfica A; Pesquero JB; Bader M; Witherden DA; Havran WL; Calixto JB; Otuki MF; Cabrini DA
Br J Pharmacol; 2020 Aug; 177(15):3535-3551. PubMed ID: 32335893
[TBL] [Abstract][Full Text] [Related]
16. The relevance of kalikrein-kinin system via activation of B
Soares DM; Santos DR; Rummel C; Ott D; Melo MCC; Roth J; Calixto JB; Souza GEP
Neuropharmacology; 2017 Nov; 126():84-96. PubMed ID: 28826826
[TBL] [Abstract][Full Text] [Related]
17. Kinin receptors and their antagonists as novel therapeutic agents.
Oztürk Y
Curr Pharm Des; 2001 Jan; 7(2):135-61. PubMed ID: 11172705
[TBL] [Abstract][Full Text] [Related]
18. Kinin B1 receptors as a therapeutic target for inflammation.
Qadri F; Bader M
Expert Opin Ther Targets; 2018 Jan; 22(1):31-44. PubMed ID: 29168929
[TBL] [Abstract][Full Text] [Related]
19. An overview of kinin mediated events in cancer progression and therapeutic applications.
Deepak K; Roy PK; Kola P; Mukherjee B; Mandal M
Biochim Biophys Acta Rev Cancer; 2022 Nov; 1877(6):188807. PubMed ID: 36167271
[TBL] [Abstract][Full Text] [Related]
20. Kinin B
Becker G; Fialho MFP; Brusco I; Oliveira SM
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
